- Business Wire•7 hours ago
Biogen Inc. today announced it will report first quarter 2017 financial results on Tuesday, April 25, 2017, before the financial markets open.
- Investopedia•5 days ago
Cytokinetics' spinal muscular atrophy drug, CK-2127107, improved muscle function in a pre-clinical study.
- Zacks•6 days ago
Biotech stocks were hit by the 2018 budget blueprint as well as news on companies like Amgen (AMGN) and Biogen.
BIIB : Summary for Biogen Inc. - Yahoo Finance
Biogen Inc. (BIIB)
NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
|Bid||260.65 x 200|
|Ask||283.68 x 100|
|Day's Range||272.34 - 276.71|
|52 Week Range||223.02 - 333.65|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||16.26|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|